首页> American journal of hematology> The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.

The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Giuseppe G,Loscocco

第一单位： Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.;Doctorate School GenOMec, University of Siena, Siena, Italy.

作者： Giuseppe G,Loscocco ^[1] ; Giada,Rotunno ^[2] ; Francesco,Mannelli ^[2] ; Giacomo,Coltro ^[2] ; Francesca,Gesullo ^[2] ; Fabiana,Pancani ^[2] ; Leonardo,Signori ^[2] ; Chiara,Maccari ^[2] ; Maria,Esposito ^[2] ; Chiara,Paoli ^[2] ; Alessandro M,Vannucchi ^[2] ; Paola,Guglielmelli ^[2]

作者单位： Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.;Doctorate School GenOMec, University of Siena, Siena, Italy. ^[1] Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy. ^[2]